Literature DB >> 6254020

Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.

E Melamed, F Hefti, R J Wurtman.   

Abstract

Partial, unilateral nigrostriatal lesions of varying severity were produced in rats by injecting graded doses of 6-hydroxydopamine into the substantia nigra. Formation of the dopamine metabolites dihydroxyphenylacetic acid and homovanillic acid in each surviving nigrostriatal neuron (estimated by the ratios of dihydroxyphenylacetic acid to dopamine and homovanillic acid to dopamine in the striatum) increased significantly when dopamine concentrations in striata containing lesions had been reduced to 25% or less of control values, but remained unchanged in rats with less severe lesions. These findings suggest that, in rats with severe damage of nigrostriatal dopaminergic neurons, surviving neurons increase their firing rates and accelerate dopamine synthesis and release. In rats that had lesions and enhanced striatal dopamine release, but not in rats with lesser lesions (i.e., which reduced ipsilateral dopamine concentrations by less than 75%), administration of tyrosine (250 mg/kg) caused further significant increases in formation of dihydroxyphenylacetic acid and homovanillic acid. These findings provide further evidence that tyrosine availability can enhance dopamine synthesis in and release from nigrostriatal neurons if the firing rates of these neurons are accelerated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254020      PMCID: PMC349822          DOI: 10.1073/pnas.77.7.4305

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.

Authors:  B S Bunney; J R Walters; R H Roth; G K Aghajanian
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

2.  Sustained levodopa therapy in parkinsonism.

Authors:  K R Hunter; K M Shaw; D R Laurence; G M Stern
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

3.  Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.

Authors:  Y Agid; F Javoy; J Glowinski
Journal:  Nat New Biol       Date:  1973-10-03

4.  Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study.

Authors:  C Sotelo; F Javoy; Y Agid; J Glowinski
Journal:  Brain Res       Date:  1973-08-30       Impact factor: 3.252

5.  Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.

Authors:  W H Oldendorf
Journal:  Am J Physiol       Date:  1971-12

6.  [Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].

Authors:  H Bernheimer; O Hornykiewicz
Journal:  Klin Wochenschr       Date:  1965-07-01

7.  Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease.

Authors:  U K Rinne; V Sonninen; M Hyyppä
Journal:  Life Sci I       Date:  1971-05-15

8.  Temporal changes in amine synthesizing enzymes of rat extrapyramidal structures after hemitransections or 6-hydroxydopamine administration.

Authors:  E G McGeer; H C Fibiger; P L McGeer; S Brooke
Journal:  Brain Res       Date:  1973-03-30       Impact factor: 3.252

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  Brain serotonin content: physiological dependence on plasma tryptophan levels.

Authors:  J D Fernstrom; R J Wurtman
Journal:  Science       Date:  1971-07-09       Impact factor: 47.728

View more
  11 in total

1.  Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.

Authors:  J M Rabey; Y Vered; H Shabtai; E Graff; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.

Authors:  George E Jaskiw; Bobbi Kirkbride; Erica Newbould; Damon Young; Valerie Durkalski; Rodolfo Bongiovanni
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

3.  Dietary supplementation of tyrosine prevents the rapid fall in blood pressure during haemorrhage.

Authors:  F A Moya-Huff; J M Pinto; P J Kiritsy; T J Maher
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Oral tyrosine supplementation improves exercise capacity in the heat.

Authors:  Les Tumilty; Glen Davison; Manfred Beckmann; Rhys Thatcher
Journal:  Eur J Appl Physiol       Date:  2011-03-25       Impact factor: 3.078

5.  Regional tyrosine levels in rat brain after tyrosine administration.

Authors:  M C Morre; F Hefti; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  Mesocortical dopamine neurons: high basal firing frequency predicts tyrosine dependence of dopamine synthesis.

Authors:  S Y Tam; J D Elsworth; C W Bradberry; R H Roth
Journal:  J Neural Transm Gen Sect       Date:  1990

7.  Tyrosine administration enhances dopamine synthesis and release in light-activated rat retina.

Authors:  C J Gibson; C J Watkins; R J Wurtman
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

8.  Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain.

Authors:  Marisa Le Masurier; Philip J Cowen; Trevor Sharp
Journal:  Psychopharmacology (Berl)       Date:  2003-09-30       Impact factor: 4.530

9.  Effect of tyrosine on brain catecholamine turnover in reserpine-treated rats.

Authors:  T Oishi; R J Wurtman
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

10.  Homeostatic mechanisms in dopamine synthesis and release: a mathematical model.

Authors:  Janet A Best; H Frederik Nijhout; Michael C Reed
Journal:  Theor Biol Med Model       Date:  2009-09-10       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.